Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2024	Jun. 30, 2023
Current assets:
Cash and Cash Equivalents, at Carrying Value	$ 203,775	$ 130,313
Marketable Securities, Current	4,500	38,540
Accounts receivable, net of allowances of $7,219 and $6,630, respectively	64,576	67,353
Inventory	97,016	107,835
Prepaid expenses and other current assets	88,112	96,986
Total current assets	457,979	441,027
Property, plant and equipment, net	265,177	287,574
Operating lease assets, net	78,681	76,776
Software and website development costs, net	92,212	95,315
Deferred tax assets	95,059	12,740
Goodwill	787,138	781,541
Intangible assets, net	76,560	109,196
Marketable securities, non-current	0	4,497
Other assets	39,351	46,193
Total assets	1,892,157	1,854,859
Current liabilities:
Accounts payable	326,656	285,784
Accrued expenses	245,931	257,109
Deferred revenue	46,118	44,698
Short-term debt	12,488	10,713
Operating lease liabilities, current	19,634	22,559
Other current liabilities	13,136	24,469
Total current liabilities	663,963	645,332
Deferred tax liabilities	24,701	47,351
Long-term debt	1,591,807	1,627,243
Operating lease liabilities, non-current	61,895	56,668
Other liabilities	76,305	90,058
Total liabilities	2,418,671	2,466,652
Temporary equity
Redeemable noncontrolling interests (Note 14)	22,998	10,893
Shareholders’ deficit:
Preferred shares, nominal value €0.01 per share, 100,000,000 shares authorized; none issued and outstanding	0	0
Ordinary shares, nominal value €0.01 per share, 100,000,000 shares authorized; 43,051,269 and 44,315,855 shares issued, respectively; 25,080,022 and 26,344,608 shares outstanding, respectively	604	615
Treasury shares, at cost, 17,971,247 shares for both periods presented	(1,363,550)	(1,363,550)
Additional paid-in capital	570,283	539,454
Retained earnings	272,881	235,396
Accumulated other comprehensive loss	(30,364)	(35,060)
Total shareholders’ deficit attributable to Cimpress plc	(550,146)	(623,145)
Noncontrolling Interest	634	459
Total shareholders' deficit	(549,512)	(622,686)
Total liabilities, noncontrolling interests and shareholders’ deficit	$ 1,892,157	$ 1,854,859